1 1116 131 EFFICACY OF A VALIDATED YOGA PROTOCOL ON DYSLIPIDEMIA IN DIABETES PATIENTS: NMB-2017 INDIA TRIAL. BACKGROUND: DYSLIPIDEMIA IS CONSIDERED A RISK FACTOR IN TYPE 2 DIABETES MELLITUS (T2DM) RESULTING IN CARDIO-VASCULAR COMPLICATIONS. YOGA PRACTICES HAVE SHOWN PROMISING RESULTS IN ALLEVIATING TYPE 2 DIABETES PATHOLOGY. METHOD: IN THIS STRATIFIED TRIAL ON A YOGA BASED LIFESTYLE PROGRAM IN CASES WITH TYPE 2 DIABETES, IN THE RURAL AND URBAN POPULATION FROM ALL ZONES OF INDIA, A TOTAL OF 17,012 ADULTS (>20 YEARS) OF BOTH GENDERS WERE SCREENED FOR LIPID PROFILE AND SUGAR LEVELS. THOSE WHO SATISFIED THE SELECTION CRITERIA WERE TAUGHT THE DIABETES YOGA PROTOCOL (DYP) FOR THREE MONTHS AND THE DATA WERE ANALYZED. RESULTS: AMONG THOSE WITH DIABETES, 29.1% HAD ELEVATED TOTAL CHOLESTEROL (TC > 200 MG/DL) LEVELS THAT WERE HIGHER IN URBAN (69%) THAN RURAL (31%) DIABETES PATIENTS. THERE WAS A POSITIVE CORRELATION (P = 0.048) BETWEEN HBA1C AND TOTAL CHOLESTEROL LEVELS. DYP INTERVENTION HELPED IN REDUCING TC FROM 232.34 +/- 31.48 MG/DL TO 189.38 +/- 40.23 MG/DL WITH SIGNIFICANT PRE POST DIFFERENCE (P < 0.001). CONVERSION RATE FROM HIGH TC (>200 MG/DL) TO NORMAL TC (<200 MG/DL) WAS OBSERVED IN 60.3% OF CASES WITH TYPE 2 DIABETES MELLITUS (T2DM); FROM HIGH LDL (>130 MG/DL) TO NORMAL LDL (<130 MG/DL) IN 73.7%; FROM HIGH TRIGLYCERIDE (>200 MG/DL) TO NORMAL TRIGLYCERIDE LEVEL (<200 MG/DL) IN 63%; FROM LOW HDL (<45 MG/DL) TO NORMAL HDL (>45 MG/DL) IN 43.7% OF T2DM PATIENTS AFTER THREE MONTHS OF DYP. CONCLUSIONS: A YOGA LIFESTYLE PROGRAM DESIGNED SPECIFICALLY TO MANAGE DIABETES HELPS IN REDUCING THE CO-MORBIDITY OF DYSLIPIDEMIA IN CASES OF PATIENTS WITH T2DM. 2019 2 959 36 EFFECTS OF A YOGA INTERVENTION ON LIPID PROFILES OF DIABETES PATIENTS WITH DYSLIPIDEMIA. OBJECTIVE: THE PRESENT STUDY WAS CONDUCTED TO ASSESS THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS. METHODS: THIS RANDOMIZED PARALLEL STUDY WAS CARRIED OUT IN MEDICAL COLLEGE TRIVANDRUM, KERALA, INDIA. HUNDRED TYPE 2 DIABETICS WITH DYSLIPIDEMIA WERE RANDOMIZED INTO CONTROL AND YOGA GROUPS. THE CONTROL GROUP WAS PRESCRIBED ORAL HYPOGLYCEMIC DRUGS. THE YOGA GROUP PRACTICED YOGA DAILY FOR 1 H DURATION ALONG WITH ORAL HYPOGLYCEMIC DRUGS FOR 3 MONTHS. THE LIPID PROFILES OF BOTH THE GROUPS WERE COMPARED AT THE START AND AT THE END OF 3 MONTHS. RESULTS: AFTER INTERVENTION WITH YOGA FOR A PERIOD OF 3 MONTHS THE STUDY GROUP SHOWED A DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES AND LDL, WITH AN IMPROVEMENT IN HDL. CONCLUSION: YOGA, BEING A LIFESTYLE INCORPORATING EXERCISE AND STRESS MANAGEMENT TRAINING, TARGETS THE ELEVATED LIPID LEVELS IN PATIENTS WITH DIABETES THROUGH INTEGRATED APPROACHES. 2013 3 1374 41 IMPACT OF AN INTEGRATED YOGA THERAPY PROTOCOL ON INSULIN RESISTANCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. OBJECTIVE: DIABETES MELLITUS (DM), CHARACTERIZED BY CHRONIC HYPERGLYCEMIA, IS ATTRIBUTED TO RELATIVE INSULIN DEFICIENCY OR RESISTANCE, OR BOTH. STUDIES HAVE SHOWN THAT YOGA CAN MODULATE PARAMETERS OF INSULIN RESISTANCE. THE PRESENT STUDY EXPLORED THE POSSIBLE BENEFICIAL EFFECTS OF INTEGRATED YOGA THERAPY WITH REFERENCE TO GLYCEMIC CONTROL AND INSULIN RESISTANCE (IR) IN INDIVIDUALS WITH DIABETES MAINTAINED ON STANDARD ORAL MEDICAL CARE WITH YOGA THERAPY, COMPARED TO THOSE ON STANDARD ORAL MEDICAL CARE ALONE. METHODS: IN THIS STUDY, THE SUBJECTS ON YOGA INTERVENTION COMPRISED 35 TYPE 2 DIABETICS, AND AN EQUAL NUMBER OF VOLUNTEERS CONSTITUTED THE CONTROL GROUP. SUBJECTS RANGED IN AGE FROM 30 TO 70 YEARS, WITH HEMOGLOBIN A1C (HBA1C) TEST MORE THAN 7%, AND WERE MAINTAINED ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS. BLOOD SAMPLES WERE DRAWN PRIOR TO AND AFTER 120 DAYS OF INTEGRATED YOGA THERAPY INTERVENTION. FASTING BLOOD GLUCOSE (FBG), POST-PRANDIAL BLOOD GLUCOSE (PPBG), HBA1C, INSULIN, AND LIPID PROFILE WERE ASSESSED IN BOTH THE INTERVENTION AND CONTROL GROUPS. RESULTS: THE INTERVENTION GROUP REVEALED SIGNIFICANT IMPROVEMENTS IN BODY MASS INDEX (BMI) (0.7 KG/M(2) MEDIAN DECREASE; P=0.001), FBG (20 MG/DL MEDIAN DECREASE; P<0.001), PPBG (33 MG/DL MEDIAN DECREASE; P<0.001), HBA1C (0.4% MEDIAN DECREASE; P<0.001), HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE (HOMA-IR) (1.2 MEDIAN DECREASE; P<0.001), CHOLESTEROL (13 MG/DL MEDIAN DECREASE, P=0.006), TRIACYLGLYCEROL (22 MG/DL MEDIAN DECREASE; P=0.027), LOW-DENSITY LIPOPROTEIN (6 MG/DL MEDIAN DECREASE; P=0.004), AND VERY-LOW-DENSITY LIPOPROTEIN LEVELS (4 MG/DL MEDIAN DECREASE; P=0.032). INCREASES IN HIGH-DENSITY LIPOPROTEIN AFTER 120 DAYS WERE NOT SIGNIFICANT (6 MG/DL MEDIAN INCREASE; P=0.15). HOWEVER, WHEN COMPARED TO CHANGES OBSERVED IN PATIENTS IN THE CONTROL GROUP, ALL THESE IMPROVEMENTS PROVED TO BE SIGNIFICANT. CONCLUSION: ADMINISTRATION OF INTEGRATED YOGA THERAPY TO INDIVIDUALS WITH DIABETES LEADS TO A SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL, INSULIN RESISTANCE, AND KEY BIOCHEMICAL PARAMETERS. 2022 4 926 54 EFFECTIVENESS OF YOGA LIFESTYLE ON LIPID METABOLISM IN A VULNERABLE POPULATION-A COMMUNITY BASED MULTICENTER RANDOMIZED CONTROLLED TRIAL. BACKGROUND: DYSLIPIDEMIA POSES A HIGH RISK FOR CARDIOVASCULAR DISEASE AND STROKE IN TYPE 2 DIABETES (T2DM). THERE ARE NO STUDIES ON THE IMPACT OF A VALIDATED INTEGRATED YOGA LIFESTYLE PROTOCOL ON LIPID PROFILES IN A HIGH-RISK DIABETES POPULATION. METHODS: HERE, WE REPORT THE RESULTS OF LIPID PROFILE VALUES OF 11,254 (YOGA 5932 AND CONTROL 5322) ADULTS (20-70 YEARS) OF BOTH GENDERS WITH HIGH RISK (>/=60 ON INDIAN DIABETES RISK SCORE) FOR DIABETES FROM A NATIONWIDE RURAL AND URBAN COMMUNITY-BASED TWO GROUP (YOGA AND CONVENTIONAL MANAGEMENT) CLUSTER RANDOMIZED CONTROLLED TRIAL. THE YOGA GROUP PRACTICED A VALIDATED INTEGRATED YOGA LIFESTYLE PROTOCOL (DYP) IN NINE DAY CAMPS FOLLOWED BY DAILY ONE-HOUR PRACTICE. BIOCHEMICAL PROFILING INCLUDED GLYCATED HEMOGLOBIN AND LIPID PROFILES BEFORE AND AFTER THREE MONTHS. RESULTS: THERE WAS A SIGNIFICANT DIFFERENCE BETWEEN GROUPS (P < 0.001 ANCOVA) WITH IMPROVED SERUM TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND HIGH-DENSITY LIPOPROTEIN IN THE YOGA GROUP COMPARED TO THE CONTROL GROUP. FURTHER, THE REGULATORY EFFECT OF YOGA WAS NOTED WITH A SIGNIFICANT DECREASE OR INCREASE IN THOSE WITH HIGH OR LOW VALUES OF LIPIDS, RESPECTIVELY, WITH MARGINAL OR NO CHANGE IN THOSE WITHIN THE NORMAL RANGE. CONCLUSION: YOGA LIFESTYLE IMPROVES AND REGULATES (LOWERED IF HIGH, INCREASED IF LOW) THE BLOOD LIPID LEVELS IN BOTH GENDERS OF PREDIABETIC AND DIABETIC INDIVIDUALS IN BOTH RURAL AND URBAN INDIAN COMMUNITIES. 2021 5 625 33 DIABETIC YOGA PROTOCOL IMPROVES GLYCEMIC, ANTHROPOMETRIC AND LIPID LEVELS IN HIGH RISK INDIVIDUALS FOR DIABETES: A RANDOMIZED CONTROLLED TRIAL FROM NORTHERN INDIA. PURPOSE: TO STUDY THE EFFECTIVENESS OF DIABETIC YOGA PROTOCOL (DYP) AGAINST MANAGEMENT OF CARDIOVASCULAR RISK PROFILE IN A HIGH-RISK COMMUNITY FOR DIABETES, FROM CHANDIGARH, INDIA. METHODS: THE STUDY WAS A RANDOMIZED CONTROLLED TRIAL, CONDUCTED AS A SUB STUDY OF THE PAN INDIA TRIAL NIYANTRITA MADHUMEHA BHARATH (NMB). THE COHORT WAS IDENTIFIED THROUGH THE INDIAN DIABETES RISK SCORING (IDRS) (>/= 60) AND A TOTAL OF 184 INDIVIDUALS WERE RANDOMIZED INTO INTERVENTION (N = 91) AND CONTROL GROUPS (N = 93). THE DYP GROUP UNDERWENT THE SPECIFIC DYP TRAINING WHEREAS THE CONTROL GROUP FOLLOWED THEIR DAILY REGIMEN. THE STUDY OUTCOMES INCLUDED CHANGES IN GLYCEMIC AND LIPID PROFILE. ANALYSIS WAS DONE UNDER INTENT-TO-TREAT PRINCIPLE. RESULTS: THE 3 MONTHS DYP PRACTICE SHOWED DIVERSE RESULTS SHOWING GLYCEMIC AND LIPID PROFILE OF THE HIGH RISK INDIVIDUALS. THREE MONTHS OF DYP INTERVENTION WAS FOUND TO SIGNIFICANTLY REDUCE THE LEVELS OF POST-PRANDIAL GLUCOSE LEVELS (P = 0.035) AND LDL-C LEVELS (P = 0.014) AND WAIST CIRCUMFERENCE (P = 0.001). CONCLUSION: THE FINDINGS INDICATE THAT THE DYP INTERVENTION COULD IMPROVE THE METABOLIC STATUS OF THE HIGH-DIABETES-RISK INDIVIDUALS WITH RESPECT TO THEIR GLUCOSE TOLERANCE AND LIPID LEVELS, PARTIALLY EXPLAINED BY THE REDUCTION IN ABDOMINAL OBESITY. THE STUDY HIGHLIGHTS THE POTENTIAL ROLE OF YOGA INTERVENTION IN REAL TIME IMPROVEMENT OF CARDIOVASCULAR PROFILE IN A HIGH DIABETES RISK COHORT. TRIAL REGISTRATION: CTRI, CTRI/2018/03/012804. REGISTERED 01 MARCH 2018-RETROSPECTIVELY REGISTERED, HTTP://WWW.CTRI.NIC.IN/ CTRI/2018/03/012804. 2021 6 882 40 EFFECT OF YOGA TRAINING ON LIPID METABOLISM IN INDUSTRIAL WORKERS WITH REFERENCE TO BODY CONSTITUTION (PRAKRITI). INTRODUCTION: THE PROGRESSIVE INCREASE IN DYSLIPIDEMIA AND PHYSICAL INACTIVITY ARE CONSIDERED TO BE MAJOR RISK FACTORS FOR THE ONSET OF NON COMMUNICABLE DISEASES. AWARENESS OF BODY CONSTITUTION PLAYS A VITAL ROLE TO REGULARISE OPTIMUM HEALTH. THE PRESENT STUDY WAS PLANNED TO EVALUATE THE EFFECT OF YOGA PRACTICES ON LIPID METABOLISM WITH REFERENCE TO SPECIFIC BODY CONSTITUTION (PRAKRITI). METHODS: A SELF-AS-CONTROL STUDY WAS CONDUCTED ON 36 MALE HEALTHY VOLUNTEERS BETWEEN AGE GROUP OF 30-58 YEARS. THEIR PRAKRITI ANALYSIS WAS DONE USING STANDARDIZED, VALIDATED QUESTIONNAIRE AND WERE DIVIDED INTO VATA-PITTA (N = 16) AND PITTA-KAPHA (N = 20) GROUPS. THE ASSESSMENT OF LIPID PROFILE WAS DONE IN FASTING BLOOD SAMPLES BEFORE AND AFTER 12 WEEKS OF YOGA TRAINING. DATA WERE ANALYZED USING PAIRED T-TEST AND INDEPENDENT T-TEST. RESULTS: AFTER YOGA INTERVENTION, THE RESULT OF WITHIN GROUP COMPARISON REVEALED THAT IN VATA-PITTA (V-P) GROUP, SIGNIFICANT DECREASE IN THE LEVELS OF TC, LDL (P < 0.001) AND SIGNIFICANT INCREASE IN HDL (P < 0.01) WAS OBSERVED. WHILE, PITTA-KAPHA (P-K) GROUP SHOWED SIGNIFICANT DECREASE IN TC (P < 0.001), TG (P < 0.01), LDL (P < 0.001) AND VLDL (P < 0.05) LEVELS. FURTHER, THE RESULTS BETWEEN GROUPS REVEALED THAT P-K GROUP HAS SIGNIFICANTLY HIGHER BASELINE LEVELS OF TC, TG AND VLDL AS COMPARED TO V-P GROUP (P < 0.05). CONCLUSION: THE STUDY CONCLUDES THAT YOGA PRACTICES CAN EFFECTIVELY REGULATE LIPID METABOLISM AND TOTAL BODY ENERGY EXPENDITURE WITH REFERENCE TO SPECIFIC CONSTITUTIONAL TYPE (PRAKRITI) THAT MAY ACT AS A TOOL TO ASSESS MAGNITUDE OF METABOLIC FUNCTIONS. 2017 7 938 35 EFFECTS OF 1-YEAR YOGA ON CARDIOVASCULAR RISK FACTORS IN MIDDLE-AGED AND OLDER ADULTS WITH METABOLIC SYNDROME: A RANDOMIZED TRIAL. BACKGROUND: METABOLIC SYNDROME (METS) IS A CLUSTERING OF CARDIOVASCULAR RISK FACTORS, WHICH IS ASSOCIATED WITH DIABETES MELLITUS AND CARDIOVASCULAR DISEASE. LIFESTYLE INTERVENTIONS APPLIED TO PEOPLE WITH METS HAS CONSIDERABLE BENEFICIAL EFFECTS ON DISEASE PREVENTIVE OUTCOMES. THIS STUDY AIMED TO EXAMINE THE EFFECTS OF 1-YEAR OF YOGA EXERCISE ON THE CARDIOVASCULAR RISK FACTORS INCLUDING CENTRAL OBESITY, HYPERTENSION, DYSLIPIDEMIA AND HYPERGLYCEMIA IN MIDDLE-AGED AND OLDER HONG KONG CHINESE ADULTS WITH METS. METHODS: ADULTS DIAGNOSED WITH METS USING NATIONAL CHOLESTEROL EDUCATION PROGRAM CRITERIA (N = 182; MEAN +/- SD AGE = 56 +/- 9.1) WERE RANDOMLY ASSIGNED TO A 1-YEAR YOGA INTERVENTION GROUP OR CONTROL GROUP. SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, WAIST CIRCUMFERENCE, FASTING PLASMA GLUCOSE, TRIGLYCERIDES, AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WERE EXAMINED AT BASELINE, MIDWAY, AND ON COMPLETION OF THE STUDY. PHYSICAL ACTIVITY LEVEL AND CALORIC INTAKE WERE ASSESSED AND INCLUDED IN THE COVARIATE ANALYSES. RESULTS: A REDUCTION OF THE NUMBER OF DIAGNOSTIC COMPONENTS FOR METS WAS FOUND TO BE ASSOCIATED WITH THE YOGA INTERVENTION. WAIST CIRCUMFERENCE WAS SIGNIFICANTLY IMPROVED AFTER THE 1-YEAR YOGA INTERVENTION. A TREND TOWARDS A DECREASE IN SYSTOLIC BLOOD PRESSURE WAS OBSERVED FOLLOWING YOGA INTERVENTION. CONCLUSION: THESE RESULTS SUGGEST THAT YOGA EXERCISE IMPROVES THE CARDIOVASCULAR RISK FACTORS INCLUDING CENTRAL OBESITY AND BLOOD PRESSURE IN MIDDLE-AGED AND OLDER ADULTS WITH METS. THESE FINDINGS SUPPORT THE COMPLEMENTARY BENEFICIAL ROLE OF YOGA IN MANAGING METS. 2015 8 1030 29 EFFECTS OF YOGA EXERCISE ON SERUM ADIPONECTIN AND METABOLIC SYNDROME FACTORS IN OBESE POSTMENOPAUSAL WOMEN. OBJECTIVE: REGULAR AND CONTINUOUS YOGA EXERCISE IS ONE OF THE MOST IMPORTANT NONPHARMACOLOGICAL METHODS OF IMPROVING SERUM LIPID CONCENTRATIONS, ADIPOSE TISSUE, AND METABOLIC SYNDROME FACTORS. THE PURPOSE OF THIS STUDY WAS TO ANALYZE THE EFFECTS OF YOGA EXERCISE ON SERUM ADIPONECTIN AND METABOLIC SYNDROME FACTORS IN OBESE POSTMENOPAUSAL KOREAN WOMEN. METHODS: SIXTEEN HEALTHY POSTMENOPAUSAL WOMEN AGED 54.50 +/- 2.75 YEARS WITH MORE THAN 36% BODY FAT WERE RANDOMLY ASSIGNED TO EITHER A YOGA EXERCISE GROUP (N = 8) OR TO A "NO EXERCISE" CONTROL GROUP (N = 8). THE VARIABLES OF BODY COMPOSITION, VISCERAL FAT, SERUM ADIPONECTIN, AND METABOLIC SYNDROME FACTORS WERE MEASURED IN ALL THE PARTICIPANTS BEFORE AND AFTER THE 16-WEEK STUDY. RESULTS: BODY WEIGHT, PERCENTAGE OF BODY FAT, LEAN BODY MASS, BODY MASS INDEX, WAIST CIRCUMFERENCE, AND VISCERAL FAT AREA HAD SIGNIFICANTLY DECREASED. HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND ADIPONECTIN HAD SIGNIFICANTLY INCREASED, BUT TOTAL CHOLESTEROL, TRIGLYCERIDE, LOW-DENSITY LIPOPROTEIN CHOLESTEROL, BLOOD PRESSURE, INSULIN, GLUCOSE, AND HOMOEOSTASIS MODEL ASSESSMENT-INSULIN RESISTANCE HAD SIGNIFICANTLY DECREASED. SERUM ADIPONECTIN CONCENTRATIONS WERE SIGNIFICANTLY CORRELATED WITH WAIST CIRCUMFERENCE, HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, DIASTOLIC BLOOD PRESSURE, AND HOMOEOSTASIS MODEL ASSESSMENT-INSULIN RESISTANCE IN THE POSTYOGA EXERCISE GROUP. CONCLUSIONS: OUR FINDINGS INDICATE THAT YOGA EXERCISE IMPROVES ADIPONECTIN LEVEL, SERUM LIPIDS, AND METABOLIC SYNDROME RISK FACTORS IN OBESE POSTMENOPAUSAL WOMEN. CONSEQUENTLY, YOGA EXERCISE WILL BE EFFECTIVE IN PREVENTING CARDIOVASCULAR DISEASE CAUSED BY OBESITY IN OBESE POSTMENOPAUSAL KOREAN WOMEN. 2012 9 1476 36 INTEGRATED YOGA AND NATUROPATHY MODULE IN MANAGEMENT OF METABOLIC SYNDROME: A CASE REPORT. A 50-YEAR-OLD MALE PARTICIPANT WITH SEDENTARY LIFESTYLE, DIAGNOSED WITH METABOLIC SYNDROME (METS) [OBESITY, TYPE-2 DIABETES MELLITUS, HYPERTENSION] AND HYPOTHYROIDISM SINCE 2013, WAS ADMINISTERED INTEGRATED YOGA AND NATUROPATHY (IYN) FOR 6 WEEKS AS A TAILOR MADE INDIVIDUALIZED PROTOCOL AT THE RESIDENTIAL INTEGRATIVE MEDICAL FACILITY IN BANGALORE BETWEEN OCTOBER AND NOVEMBER 2015. THE RESULTS SHOWED REDUCTION IN WEIGHT (97.9 KG TO 74.6 KG), BODY MASS INDEX (BMI) (35.1 KG/M(2) TO 27.86 KG/M(2)), TOTAL CHOLESTEROL (192 MG% TO 145 MG%), TRIGLYCERIDES (153 MG% TO 90 MG%), LOW DENSITY LIPOPROTEIN (LDL) (124 MG% TO 81 MG%), HIGH DENSITY LIPOPROTEIN (HDL) (40 MG% TO 46 MG%), FASTING BLOOD GLUCOSE (110 MG/DL TO 75 MG/DL), POSTPRANDIAL GLUCOSE (267 MG/DL TO 100 MG/DL), GLYCATED HEMOGLOBIN (HBA1C) (7.8%-7.1%), THYROID STIMULATING HORMONE (TSH) (6.90 MUIU/ML TO 3.052 MUIU/ML). FOLLOWING THE INTERVENTION, THE ANTI-HYPERTENSIVE, ORAL HYPOGLYCEMIC, THYROID RAISING AND ANALGESIC MEDICINES WERE NOT REQUIRED TO BE CONTINUED. HIS KNEE PAIN MINIMIZED ON DISCHARGE AS OBSERVED ON A VISUAL ANALOG SCALE. HE HAD AN IMPROVED FEELING OF WELLNESS AND OVERALL FUNCTIONAL HEALTH. ALL HIS PARAMETERS WERE WITHIN NORMAL RANGE AT THE 12-WEEKS FOLLOW-UP, AS HE HAD INCORPORATED THE LIFESTYLE PROGRAM INTO HIS DAILY ROUTINE. THIS CASE REPORT SUGGESTS THAT LIFESTYLE CHANGE BY INTEGRATION OF SPECIFIC NON-DRUG YOGA AND NATUROPATHIC INTERVENTION IS USEFUL IN THE MANAGEMENT OF METS. 2017 10 1703 28 PARTITIONING OF RADIOLOGICAL, STRESS AND BIOCHEMICAL CHANGES IN PRE-DIABETIC WOMEN SUBJECTED TO DIABETIC YOGA PROTOCOL. BACKGROUND: YOGA IS AN ANCIENT SYSTEM OF WELLNESS WITH ASANA AND PRANAYAMA AS ITS MOST POPULAR AND PROPAGATED MODULES FOR MANAGEMENT OF LIFESTYLE DISORDERS. OBJECTIVES: THE AIM OF THE STUDY WAS TO CHARACTERISE THE LIVER ABNORMALITIES, BIOCHEMICAL CHANGES, AND STRESS LEVELS AFTER YOGA INTERVENTION IN PREDIABETIC FEMALES. MATERIALS AND METHODS: 37 FEMALES WERE RANDOMLY DIVIDED INTO YOGA PRACTISING AND NON-PRACTISING CONTROL GROUPS. THE YOGA PRACTISING GROUP PERFORMED DIABETIC YOGA PROTOCOL (DYP) FOR 3 MONTHS. PARAMETERS INCLUDING SIZE OF LIVER, FATTY INFILTRATION, AND GRADE OF SEVERITY WERE MEASURED USING ULTRASONOGRAPHY ALONG WITH BIOCHEMICAL PARAMETERS AND STRESS LEVELS AT BASELINE AND AFTER YOGA PRACTICE. RESULTS: THE GLYCOSYLATED HEMOGLOBIN (HBA1C) AND GLUCOSE LEVELS WERE FOUND SIGNIFICANTLY REDUCED IN PREDIABETIC (P=0.015) WOMEN AFTER PRACTISING DYP, ALTHOUGH CHOLESTEROL LEVELS INCREASED IN MENOPAUSAL WOMEN. NO ESCALATION OF FATTY LIVER WAS NOTED AMONG WOMEN PRACTISING DYP. CONCLUSION: DYP REDUCED THE HBA1C AND STRESS LEVELS AND THEREFORE, COULD BE A COST-EFFECTIVE TOOL FOR PREVENTING PREDIABETES TO DIABETES PROGRESSION. 2019 11 2463 39 YOGA AS A THERAPEUTIC INTERVENTION FOR THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS. PURPOSE: THIS STUDY AIMED TO INVESTIGATE THE EFFECTS OF 12 WEEKS YOGIC INTERVENTION ON BLOOD SUGAR AND LIPID PROFILE IN ELDER WOMEN WITH TYPE 2 DIABETES MELLITUS (T2DM). SUBJECTS AND METHODS: TWENTY ELDERLY (AGE RANGE 55-70 YEARS) T2DM WOMEN WERE DIVIDED INTO TWO GROUPS, NAMELY, YOGIC INTERVENTION GROUP (YIG: N = 10, AGE 64.70 +/- 4.03, BODY MASS INDEX [BMI] 24.26 +/- 3.40) AND CONTROL GROUP (CG: N = 10, AGE 64.40 +/- 4.79, BMI 24.28 +/- 2.36). YIG UNDERWENT YOGA PRACTICE (ASANAS, KRIYAS, PRANAYAMAS) FOR 12 WEEKS (3 SESSIONS/WEEK), WHILE THE CG CONTINUED THEIR USUAL ROUTINE ACTIVITIES. STANDING HEIGHT, BODY WEIGHT, BMI, BLOOD SUGAR, AND LIPID PROFILE WERE MEASURED BEFORE COMMENCEMENT AND AFTER 6 AND 12 WEEKS OF YOGIC INTERVENTION IN BOTH GROUPS. RESULTS: THERE WAS A SIGNIFICANT (P < 0.01) DECREASE IN FASTING PLASMA GLUCOSE, POSTPRANDIAL BLOOD SUGAR, TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND VERY LOW DENSITY LIPOPROTEIN, WITH A SIGNIFICANT (P < 0.01) INCREASE IN HIGH-DENSITY LIPOPROTEIN LEVEL FROM ITS INITIAL VALUE IN YIG, WHILE SHOWING INSIGNIFICANT RESULT IN CG. CONCLUSION: IT CAN BE SAID THAT YOGIC INTERVENTION MAY HAVE THE BENEFICIAL EFFECTS ON BLOOD SUGAR AND LIPID PROFILE IN ELDERLY WOMEN WITH T2DM. 2018 12 39 38 A BRIEF BUT COMPREHENSIVE LIFESTYLE EDUCATION PROGRAM BASED ON YOGA REDUCES RISK FACTORS FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. OBJECTIVES: THE OBJECTIVE OF THE STUDY WAS TO STUDY THE SHORT-TERM IMPACT OF A BRIEF LIFESTYLE INTERVENTION BASED ON YOGA ON SOME OF THE BIOCHEMICAL INDICATORS OF RISK FOR CARDIOVASCULAR DISEASE AND DIABETES MELLITUS. DESIGN: THE VARIABLES OF INTEREST WERE MEASURED AT THE BEGINNING (DAY 1) AND END (DAY 10) OF THE INTERVENTION USING A PRE-POST DESIGN. SETTING: THE STUDY IS THE RESULT OF OPERATIONAL RESEARCH CARRIED OUT IN OUR INTEGRAL HEALTH CLINIC (IHC). THE IHC IS AN OUTPATIENT FACILITY WHICH CONDUCTS 8-DAY LIFESTYLE MODIFICATION PROGRAMS BASED ON YOGA FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASE. A NEW COURSE BEGINS EVERY ALTERNATE WEEK OF THE YEAR. SUBJECTS: THE STUDY IS BASED ON DATA COLLECTED ON 98 SUBJECTS (67 MALE, 31 FEMALE), AGES 20-74 YEARS, WHO ATTENDED ONE OF OUR PROGRAMS. THE SUBJECTS WERE A HETEROGENEOUS GROUP OF PATIENTS WITH HYPERTENSION, CORONARY ARTERY DISEASE, DIABETES MELLITUS, AND A VARIETY OF OTHER ILLNESSES. INTERVENTION: THE INTERVENTION CONSISTED OF ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), RELAXATION TECHNIQUES, GROUP SUPPORT, INDIVIDUALIZED ADVICE, LECTURES AND FILMS ON THE PHILOSOPHY OF YOGA AND THE PLACE OF YOGA IN DAILY LIFE, MEDITATION, STRESS MANAGEMENT, NUTRITION, AND KNOWLEDGE ABOUT THE ILLNESS. OUTCOME MEASURES: THE OUTCOME MEASURES WERE FASTING PLASMA GLUCOSE AND SERUM LIPOPROTEIN PROFILE. THESE VARIABLES WERE DETERMINED IN FASTING BLOOD SAMPLES, TAKEN ON THE FIRST AND LAST DAY OF THE COURSE. RESULTS: FASTING PLASMA GLUCOSE, SERUM TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL, VERY- LDL CHOLESTEROL, THE RATIO OF TOTAL CHOLESTEROL TO HIGH DENSITY LIPOPROTEIN (HDL) CHOLESTEROL, AND TOTAL TRIGLYCERIDES WERE SIGNIFICANTLY LOWER, AND HDL CHOLESTEROL SIGNIFICANTLY HIGHER, ON THE LAST DAY OF THE COURSE COMPARED TO THE FIRST DAY OF THE COURSE. THE CHANGES WERE MORE MARKED IN SUBJECTS WITH HYPERGLYCEMIA OR HYPERCHOLESTEROLEMIA. CONCLUSIONS: THE OBSERVATIONS SUGGEST THAT A SHORT LIFESTYLE MODIFICATION AND STRESS MANAGEMENT EDUCATION PROGRAM LEADS TO FAVORABLE METABOLIC EFFECTS WITHIN A PERIOD OF 9 DAYS. 2005 13 1033 31 EFFECTS OF YOGA IN ADULTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS. AIMS/INTRODUCTION: A META-ANALYSIS WAS CARRIED OUT TO EVALUATE THE EFFICACY OF YOGA IN ADULTS WITH TYPE 2 DIABETES MELLITUS. MATERIALS AND METHODS: THE PUBMED, EMBASE AND COCHRANE DATABASES WERE SEARCHED TO OBTAIN ELIGIBLE RANDOMIZED CONTROLLED TRIALS. THE PRIMARY OUTCOME WAS FASTING BLOOD GLUCOSE, AND THE SECONDARY OUTCOMES INCLUDED GLYCOSYLATED HEMOGLOBIN A1C, TOTAL CHOLESTEROL, HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, LOW-DENSITY LIPOPROTEIN CHOLESTEROL, TRIGLYCERIDE AND POSTPRANDIAL BLOOD GLUCOSE. WEIGHTED MEAN DIFFERENCES AND 95% CONFIDENCE INTERVALS (CIS) WERE CALCULATED. THE I(2) STATISTIC REPRESENTED HETEROGENEITY. RESULTS: A TOTAL OF 12 RANDOMIZED CONTROLLED TRIALS WITH A TOTAL OF 864 PATIENTS MET THE INCLUSION CRITERIA. THE POOLED WEIGHTED MEAN DIFFERENCES WERE -23.72 MG/DL (95% CI -37.78 TO -9.65; P = 0.001; I(2) = 82%) FOR FASTING BLOOD GLUCOSE AND -0.47% (95% CI -0.87 TO -0.07; P = 0.02; I(2) = 82%) FOR HEMOGLOBIN A1C. THE WEIGHTED MEAN DIFFERENCES WERE -17.38 MG/DL (95% CI -27.88 TO -6.89; P = 0.001; I(2) = 0%) FOR POSTPRANDIAL BLOOD GLUCOSE, -18.50 MG/DL (95% CI -29.88 TO -7.11; P = 0.001; I(2) = 75%) FOR TOTAL CHOLESTEROL, 4.30 MG/DL (95% CI 3.25 TO 5.36; P < 0.00001; I(2) = 10%) FOR HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, -12.95 MG/DL (95% CI -18.84 TO -7.06; P < 0.0001; I(2) = 37%) FOR LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND -12.57 MG/DL (95% CI -29.91 TO 4.76; P = 0.16; I(2) = 48%) FOR TRIGLYCERIDES. CONCLUSIONS: THE AVAILABLE EVIDENCE SUGGESTS THAT YOGA BENEFITS ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS. HOWEVER, CONSIDERING THE LIMITED METHODOLOGY AND THE POTENTIAL HETEROGENEITY, FURTHER STUDIES ARE NECESSARY TO SUPPORT OUR FINDINGS AND INVESTIGATE THE LONG-TERM EFFECTS OF YOGA IN TYPE 2 DIABETES MELLITUS PATIENTS. 2017 14 881 39 EFFECT OF YOGA TRAINING ON INFLAMMATORY CYTOKINES AND C-REACTIVE PROTEIN IN EMPLOYEES OF SMALL-SCALE INDUSTRIES. OBJECTIVE: THE PRESENT STUDY INTENDS TO SEE THE EFFECT OF YOGA PRACTICES ON LIPID PROFILE, INTERLEUKIN (IL)-6, TUMOR NECROSIS FACTOR (TNF)-ALPHA, AND HIGH-SENSITIVITY-C-REACTIVE PROTEIN (HS-CRP) AMONG APPARENTLY HEALTHY ADULTS EXPOSED TO OCCUPATIONAL HAZARDS. MATERIALS AND METHODS: IN THE PRESENT STUDY, 48 PARTICIPANTS AGED 30-58 YEARS (41.5 +/- 5.2) WHO WERE EXPOSED TO OCCUPATIONAL HAZARDS WERE RANDOMIZED INTO TWO GROUPS, THAT IS, EXPERIMENTAL AND WAIT-LIST CONTROL. ALL THE PARTICIPANTS WERE ASSESSED FOR LIPID PROFILE, IL-6, TNF-ALPHA, AND HS-CRP AT THE BASELINE AND AFTER COMPLETION OF 3 MONTHS OF YOGA TRAINING INTERVENTION. THE EXPERIMENTAL GROUP UNDERWENT YOGA TRAINING INTERVENTION FOR 1 H FOR 6 DAYS A WEEK FOR 3 MONTHS, WHEREAS CONTROL GROUP CONTINUED WITH THEIR DAILY ACTIVITIES EXCEPT YOGA TRAINING. DATA ANALYSIS WAS DONE USING STATISTICAL SOFTWARE SPSS VERSION 20.0. DATA WERE ANALYZED USING PAIRED T-TESTS AND INDEPENDENT T-TEST. RESULTS: THE RESULTS OF WITHIN GROUP COMPARISON REVEALED HIGHLY SIGNIFICANT CHANGES IN CHOLESTEROL (P < 0.001), HIGH-DENSITY LIPOPROTEIN (P < 0.001), LOW-DENSITY LIPOPROTEIN (LDL)(P < 0.01), HS-CRP (P < 0.01), IL-6 (P < 0.001), AND TNF-ALPHA (P < 0.001) IN EXPERIMENTAL GROUP. COMPARISON BETWEEN EXPERIMENTAL AND CONTROL GROUP REVEALED SIGNIFICANT CHANGES IN CHOLESTEROL (P < 0.01), LDL (P < 0.05), IL-6 (P < 0.01), TNF-ALPHA (P < 0.01), AND HS-CRP (P < 0.01). CONCLUSION: A YOGA-BASED LIFESTYLE INTERVENTION SEEMS TO BE A HIGHLY PROMISING ALTERNATIVE THERAPY WHICH FAVORABLY ALTERS INFLAMMATORY MARKERS AND METABOLIC RISK FACTORS. 2017 15 663 43 EFFECT OF 6 MONTHS INTENSE YOGA PRACTICE ON LIPID PROFILE, THYROXINE MEDICATION AND SERUM TSH LEVEL IN WOMEN SUFFERING FROM HYPOTHYROIDISM: A PILOT STUDY. BACKGROUND: A SIGNIFICANT NUMBER OF WOMEN IN INDIA ARE SUFFERING FROM HYPOTHYROIDISM. HYPOTHYROIDISM IS CHARACTERIZED BY ELEVATED LIPID PROFILES AND THYROID STIMULATION HORMONE (TSH). IT LEADS MANY COMORBID CONDITIONS SUCH AS CORONARY ARTERY DISEASE, OBESITY, DEPRESSION, OSTEOPOROSIS, SLEEP APNEA, AND ETC. YOGA IS PROVEN TO BE EFFECTIVE IN REDUCING WEIGHT, DYSLIPIDEMIA, DEPRESSION AND IT BRINGS THE BALANCE IN AUTONOMOUS NERVOUS SYSTEM. WE AIMED TO STUDY THE EFFECT OF 6 MONTHS YOGA PRACTICE ON LIPID PROFILE, THYROXINE REQUIREMENT AND SERUM TSH IN WOMEN SUFFERING FROM HYPOTHYROIDISM. METHODS: TWENTY-TWO HOUSEHOLD WOMEN SUFFERING FROM HYPOTHYROIDISM BETWEEN THE AGE RANGE OF 30 AND 40 (MEAN+/-SD; 36.7+/-3.2) YEARS, WITH AVERAGE 4+/-1.12-YEAR HISTORY OF HYPOTHYROIDISM WERE INCLUDED IN THIS STUDY. SUBJECTS WITH KNOWN CARDIAC ISSUES, HYPERTENSION, HISTORY, RECENT SURGERY, SLIP DISC AND LOW BACK PAIN WERE EXCLUDED FROM THIS STUDY. NONE OF THE SUBJECTS WERE ON ANY OTHER MEDICATION EXCEPT THYROXINE WHICH WAS KEPT DURING THE INTERVENTION PHAGE (MEAN 65.78+/-22.74 MCG). ALL THE SUBJECTS UNDERWENT 6 MONTHS OF YOGA PRACTICE 1 H DAILY FOR 4 DAYS A WEEK. LIPID PROFILE, THYROXINE DOSAGE AND SERUM TSH LEVEL WERE ASSESSED BEFORE AND AFTER INTERVENTION. DATA WAS ANALYZED USING PAIRED SAMPLE T TEST & WILCOXON'S SIGNED RANK TEST. RESULTS: THE PAIRED SAMPLE T-TEST SHOWED SIGNIFICANT REDUCTION IN TOTAL CHOLESTEROL (P=0.006; -8.99%), LOW-DENSITY LIPOPROTEIN (LDL) (P=0.002; -9.81%) AND TRIGLYCERIDES (P=0.013; -7.6%), AND THERE WAS A SIGNIFICANT IMPROVEMENT IN HIGH-DENSITY LIPOPROTEIN (HDL) (P=0.02; +9.65%) ALONG WITH NONSIGNIFICANT REDUCTION IN TSH LEVEL (P=0.452; -9.72%). WILCOXON SIGNED-RANK TEST SHOWED SIGNIFICANT REDUCTION IN THYROXINE MEDICATION SCORE (P=0.029; -15.30%) FROM. CONCLUSION: 6 MONTHS PRACTICE OF YOGA MAY HELP IN IMPROVING CHOLESTEROL LEVEL, SERUM TSH, MAY ALSO HELP IN REDUCING THE THYROXINE REQUIREMENT IN FEMALE PATIENTS SUFFERING FROM HYPOTHYROIDISM. HOWEVER, FURTHER RANDOMIZED CONTROLLED STUDIES NEED TO BE CONDUCTED TO CONFIRM THE PRESENT FINDING. 2016 16 739 38 EFFECT OF RAJA YOGA MEDITATION ON THE LIPID PROFILE OF POST-MENOPAUSAL WOMEN. BACKGROUND: CORONARY ARTERY DISEASE IS AN IMPORTANT CAUSE OF DEATH AND DISABILITY AMONG OLDER WOMEN. MODIFICATION IN LIPID PROFILE LOWERS THE RISK OF CORONARY ARTERY DISEASE. IT IS CLAIMED THAT YOGA AND TRANSCENDENTAL MEDITATION HAVE A CHOLESTEROL LOWERING EFFECT. THIS STUDY WAS DESIGNED TO ASSESS THE EFFECT OF RAJA YOGA MEDITATION OF BRAHMAKUMARIS WHICH IS VERY SIMPLE TO PRACTICE, ON SERUM LIPIDS IN NORMAL INDIAN WOMEN. METHODS AND RESULTS: 49 NORMAL FEMALE VOLUNTEERS WERE THE SUBJECTS. THEY WERE DIVIDED INTO PRE-MENOPAUSAL (N=23) AND POST-MENOPAUSAL (N=26) GROUPS. THEY WERE FURTHER DIVIDED INTO NON-MEDITATORS (WHO HAD NEVER DONE ANY KIND OF MEDITATION), SHORT-TERM MEDITATORS (MEDITATING FOR 6 MONTHS TO 5 YEARS) AND LONG-TERM MEDITATORS (MEDITATING FOR MORE THAN 5 YEARS). LIPID PROFILE WAS ASSESSED USING THEIR RESPECTIVE REAGENT SETS. SERUM CHOLESTEROL, TRIGLYCERIDE AND LOW-DENSITY LIPOPROTEIN-CHOLESTEROL IN NONMEDITATORS WERE SIGNIFICANTLY MORE IN POST-MENOPAUSAL WOMEN AS COMPARED TO PRE-MENOPAUSAL WOMEN. SERUM CHOLESTEROL AND LOW DENSITY LIPOPROTEIN-CHOLESTEROL WERE SIGNIFICANTLY LOWERED IN BOTH SHORT AND LONG TERM MEDITATORS AS COMPARED TO NON-MEDITATORS IN POST-MENOPAUSAL WOMEN. NO SIGNIFICANT DIFFERENCE WAS OBSERVED IN LIPID PROFILE IN PRE-MENOPAUSAL WOMEN. CONCLUSION: RAJA YOGA MEDITATION LOWERED SERUM CHOLESTEROL AND LOW-DENSITY LIPOPROTEIN-CHOLESTEROL IN POST-MENOPAUSAL WOMEN THUS REDUCING THE RISK OF CORONARY ARTERY DISEASE IN THEM. 2008 17 691 43 EFFECT OF COMMUNITY-BASED STRUCTURED YOGA PROGRAM ON HBA1C LEVEL AMONG TYPE 2 DIABETES MELLITUS PATIENTS: AN INTERVENTIONAL STUDY. CONTEXT: IN VIEW OF THE RISING BURDEN OF TYPE 2 DIABETES MELLITUS (DM) CASES IN INDIA, THERE IS AN URGENT NEED FOR AN EFFECTIVE, LOW-COST, SUSTAINABLE INTERVENTION CONTROLLING DIABETES THUS PREVENTING COMPLICATIONS. AIMS: THIS STUDY AIMED TO ASSESS THE EFFECT OF STRUCTURED YOGA PROGRAMS ON DIABETES. SUBJECTS AND METHODS: THIS WAS A COMMUNITY-BASED INTERVENTIONAL STUDY THAT WAS CONDUCTED IN AN URBAN RESETTLEMENT COLONY OF DELHI, INDIA. KNOWN DIABETES PATIENTS WITH GLYCATED HEMOGLOBIN (HB1AC) >/=6.5% WERE ENROLLED FROM 12 RANDOMLY SELECTED BLOCKS OF THE COMMUNITY WITH A SAMPLE SIZE OF 192 IN EACH INTERVENTION AND WAIT-LISTED CONTROL ARM. THE INTERVENTION WAS STRUCTURED YOGA OF 50 MIN DAILY, 2 CONSECUTIVE WEEKS IN A NEARBY PARK AND HEALTH CENTER FOLLOWED BY TWICE A WEEK HOME PRACTICE UP TO THE 3(RD) MONTH. THE PRIMARY OUTCOME MEASURE WAS HBA1C% AND SECONDARY OUTCOME MEASURES WERE LIPID PROFILE AND FASTING BLOOD GLUCOSE. STATISTICAL ANALYSIS USED: APER-PROTOCOL ANALYSIS WAS DONE. MEAN, STANDARD DEVIATION (SD), AND 95% CONFIDENCE INTERVAL WERE ESTIMATED. THE LEVEL OF SIGNIFICANCE WAS CONSIDERED FOR 0.05. RESULTS: THERE WAS A SIGNIFICANT DECREASE OF HB1AC (0.5%, SD = 1.5, P = 0.02), TOTAL CHOLESTEROL (11.7 MG/DL, SD = 40.5, P < 0.01), AND LOW-DENSITY LIPOPROTEIN (3.2 MG/DL, SD = 37.4, P < 0.01) FROM BASELINE TO END LINE IN THE INTERVENTION GROUP. THESE CHANGES IN INTERVENTION GROUP WERE ALSO SIGNIFICANTLY DIFFERENT FROM THE CHANGE IN THE WAIT-LISTED CONTROL GROUP. THE OTHER VARIABLES DID NOT CHANGE SIGNIFICANTLY. CONCLUSIONS: IT REVEALED THAT STRUCTURED YOGA PROGRAM IMPROVED GLYCEMIC OUTCOME AND LIPID PROFILE OF INDIVIDUALS IN A COMMUNITY-BASED SETTING. YOGA CAN BE A FEASIBLE STRATEGY TO CONTROL HYPERGLYCEMIA, LIPID LEVELS, AND CAN HELP BETTER CONTROL TYPE 2 DM. 2021 18 679 30 EFFECT OF A YOGA PROGRAM ON GLUCOSE METABOLISM AND BLOOD LIPID LEVELS IN ADOLESCENT GIRLS WITH POLYCYSTIC OVARY SYNDROME. OBJECTIVE: TO ASSESS THE EFFICACY OF YOGA THERAPY ON GLUCOSE METABOLISM AND BLOOD LIPID VALUES IN ADOLESCENT GIRLS WITH POLYCYSTIC OVARY SYNDROME (PCOS). METHODS: A PROSPECTIVE, RANDOMIZED, INTERVENTIONAL CONTROLLED TRIAL RECRUITED 90 ADOLESCENTS AGED BETWEEN 15 AND 18 YEARS WHO MET THE ROTTERDAM CRITERIA FOR PCOS. A YOGA GROUP PRACTICED SURYANAMASKARA, ASANAS, PRANAYAMA, AND MEDITATION 1 HOUR PER DAY EACH DAY FOR 12 WEEKS WHILE ANOTHER GROUP PRACTICED CONVENTIONAL PHYSICAL EXERCISES. THE MANN-WHITNEY U TEST WAS USED TO COMPARE SCORE CHANGES BETWEEN THE 2 GROUPS. RESULTS: THE CHANGES IN FASTING INSULIN, FASTING BLOOD GLUCOSE, AND HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE WERE SIGNIFICANTLY DIFFERENT IN THE 2 GROUPS (P<0.05). EXCEPT FOR HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, THE CHANGES IN BLOOD LIPID VALUES WERE ALSO SIGNIFICANTLY DIFFERENT (P<0.05). THE CHANGES IN BODY MASS INDEX, WAIST CIRCUMFERENCE, HIP CIRCUMFERENCE, AND WAIST-TO-HIP RATIO, HOWEVER, WERE NOT SIGNIFICANTLY DIFFERENT (P>0.05). CONCLUSION: YOGA WAS FOUND TO BE MORE EFFECTIVE THAN CONVENTIONAL PHYSICAL EXERCISES IN IMPROVING GLUCOSE, LIPID, AND INSULIN VALUES, INCLUDING INSULIN RESISTANCE VALUES, IN ADOLESCENT GIRLS WITH PCOS INDEPENDENT OF ANTHROPOMETRIC CHANGES. CENTRAL TRIAL REGISTRY OF INDIA NO.: REFCTRI-2008 000291. 2012 19 1453 27 INFLUENCE OF PRANAYAMAS AND YOGA-ASANAS ON SERUM INSULIN, BLOOD GLUCOSE AND LIPID PROFILE IN TYPE 2 DIABETES. A DISTINGUISHABLE FEATURE OF TYPE 2 DIABETES BESIDES HYPERGLYCEMIA AND DERANGED LIPID PROFILE IS AN IMPAIRED INSULIN SECRETION, PERIPHERAL INSULIN RESISTANCE AND OBESITY WHICH HAS BECOME A MAJOR HEALTH CONCERN WORLDWIDE. INDIA WITH AN ESTIMATED 31MILLION DIABETICS IN 2000 AND 79MLLIONS BY THE YR 2030 HAS THE HIGHEST NUMBER OF TYPE 2 DIABETICS IN THE WORLD. IN THIS STUDY, WE AIMED TO SEE IF YOGA-ASANAS AND PRANAYAMAS HAVE ANY INFLUENCE IN MODIFYING CERTAIN BIOCHEMICAL PARAMETERS. SIXTY PATIENTS OF UNCOMPLICATED TYPE 2 DIABETES (AGE 35-60 YRS OF 1-10 YRS DURATION) WERE DIVIDED INTO TWO GROUPS: GROUP 1 (N=30): PERFORMED YOGA ALONG WITH THE CONVENTIONAL HYPOGLYCEMIC MEDICINES AND GROUP 2 (N=30): PATIENTS WHO ONLY RECEIVED CONVENTIONAL MEDICINES. DURATION OF THE STUDY WAS 45 DAYS. BASAL RECORDINGS OF BLOOD GLUCOSE (FASTING AND POST-PRANDIAL), LIPID PROFILE AND SERUM INSULIN WERE TAKEN AT THE TIME OF RECRUITMENT AND THE SECOND READING AFTER FORTY FIVE DAYS. RESULTS SHOWED A SIGNIFICANT IMPROVEMENT IN ALL THE BIOCHEMICAL PARAMETERS IN GROUP 1 WHILE GROUP 2 SHOWED SIGNIFICANT IMPROVEMENT IN ONLY FEW PARAMETERS, THUS SUGGESTING A BENEFICIAL EFFECT OF YOGA REGIMEN ON THESE PARAMETERS IN DIABETIC PATIENTS. 2008 20 913 32 EFFECTIVENESS OF LIQUID FASTING WITH YOGA AND NATUROPATHY TREATMENTS IN REDUCING METABOLIC AND CARDIOVASCULAR RISKS IN OBESITY. CONTEXT: OBESITY IS ASSOCIATED WITH CHRONIC DISEASES, INCLUDING METABOLIC SYNDROME AND CARDIOVASCULAR DISEASES (CVDS). FASTING IS COMMONLY EMPLOYED BY OBESE PEOPLE TO REDUCE THEIR WEIGHT. LIKEWISE, YOGA AND NATUROPATHY (YN) THAT INCLUDE LIQUID FASTING (LF) HAVE BEEN SHOWN TO BE BENEFICIAL IN REDUCING WEIGHT FOR PEOPLE WITH METABOLIC DISORDERS. HOWEVER, THE SAFETY OF LF DURING YN TREATMENTS AND ITS EFFECTS ON METABOLIC AND CARDIOVASCULAR RISK FACTORS HAVEN'T YET BEEN REPORTED. OBJECTIVE: THE STUDY INTENDED TO EVALUATE THE SAFETY OF LF DURING YN TREATMENTS AND ITS EFFECTS ON METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PEOPLE WITH OBESITY. DESIGN: A SINGLE-GROUP, PRETEST-AND-POSTTEST DESIGN WAS ADOPTED FOR THE STUDY. SETTING: THE STUDY TOOK PLACE IN A YN HOSPITAL LOCATED IN SOUTH INDIA. PARTICIPANTS: PARTICIPANTS WERE 176 OBESE PEOPLE AGED BETWEEN 18 AND 65 YEARS. INTERVENTION: TOGETHER WITH YN TREATMENTS, ALL PARTICIPANTS UNDERWENT LF USING LIME JUICE WITH JAGGERY, ASH GUARD JUICE, VEGETABLE SOUP, BUTTERMILK, AND KOKUM JUICE FOR A PERIOD OF 5 CONSECUTIVE DAYS. OUTCOME MEASURES: ASSESSMENTS SUCH AS BODY WEIGHT, BODY MASS INDEX (BMI), FAT MASS, LIPID PROFILE, AND BLOOD PRESSURE WERE TAKEN AT BASELINE AND POSTINTERVENTION. RESULTS: PARTICIPANTS SHOWED A SIGNIFICANT REDUCTION IN BODY WEIGHT, BMI, FAT MASS, TRIGLYCERIDES (TG), TOTAL CHOLESTEROL (TC), LOW-DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C), VERY-LOW-DENSITY LIPOPROTEIN CHOLESTEROL (VLDL-C), HIGH-DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C), SYSTOLIC BLOOD PRESSURE (SBP), AND DIASTOLIC BLOOD PRESSURE (DBP). CONCLUSIONS: THE RESULTS SUGGEST THAT LF DURING YN TREATMENT CANBE EFFECTIVE IN REDUCING METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PEOPLE WITH OBESITY. 2021